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OBJECTIVES To determine how well recently developed multivariables scores assess for all-cause mortality
in patients with suspected coronary disease presenting for exercise electrocardiography
(ExECG).
BACKGROUND Recently revised American College of Cardiology/American Heart Association guidelines for
ExECG have suggested that ExECG scores be used to assist in management decisions in
patients with suspected coronary artery disease. Recently developed scores accurately stratify
patients according to angiographic disease severity.
METHODS To determine how well these scores assess for all-cause mortality, we utilized 4,640 patients
without known coronary disease who underwent ExECG to evaluate symptoms of suspected
coronary disease between 1995 and 2001. Previously validated pretest and exercise test scores
as well as the Duke treadmill score were applied to each patient. All-cause mortality was our
end point.
RESULTS Overall mortality was 3.0% with 2.8  1.6 years of follow-up. All three scores stratified
patients into low-, intermediate-, and high-risk groups (p  0.00001). No differences were
seen when patients were evaluated as subgroups according to gender, diabetes, beta-blockers,
or inpatient status. Low-risk patients defined by the Duke treadmill score had consistently
higher mortality and absolute number of deaths compared with low-risk patients using other
scores. In addition, the Duke treadmill score had less incremental stratifying value than the
new exercise score.
CONCLUSIONS Simple pretest and exercise scores risk-stratified patients with suspected coronary disease in
accordance with published guidelines and better than the Duke treadmill score. These results
extend to diabetics, inpatients, women, and patients on beta-blockers. (J Am Coll Cardiol
2003;42:842–50) © 2003 by the American College of Cardiology Foundation
The simple exercise electrocardiogram (ExECG) is alive
and well, but living and existing in the shadow of exercise
imaging. Recent consensus guidelines for chronic stable
angina recommend the simple treadmill exercise ECG in a
variety of diagnostic and prognostic situations (1). American
College of Cardiology/American Heart Association (ACC/
AHA) guidelines for exercise testing suggested that pretest
See page 851
and exercise scores be utilized in the interpretation of
exercise tests and in clinical decision-making (2). Recently
developed and validated pretest and exercise scores have
demonstrated accuracy in stratifying men and women ac-
cording to the likelihood of the presence of any and severe
angiographic coronary disease (3–5). Given that these scores
were developed in angiographic populations, the purpose of
the present study was to validate them in a clinically relevant
unselected population presenting with suspected coronary
disease using the end point of all-cause mortality rather than
angiographic disease. Secondarily, we wished to validate
these scores in clinically relevant subpopulations defined by
gender and diabetic, inpatient, and beta-blocker status.
METHODS
Patient populations. Between May 1995 and February
2001, we screened all patients 18 years of age referred by
primary-care physicians and cardiologists to the stress lab-
oratory for their first exercise test. First exercise tests could
include ExECG, nuclear, or echocardiographic studies. We
included only symptomatic patients referred with the ex-
press purpose of evaluating for the presence of coronary
disease. Included in this population were inpatients admit-
ted for chest pain. These inpatients were observed for at
least 24 h and had infarction excluded by assessment of
serum markers. Those physicians caring for them as well as
those in the exercise laboratory felt they were appropriate for
exercise testing. We excluded asymptomatic patients, those
receiving digitalis preparations, those with a history of
coronary artery disease (prior myocardial infarction or cor-
onary angiography), and those with resting electrocardio-
grams (ECGs) that were considered uninterpretable (left
ventricular hypertrophy, left bundle branch block, Wolff-
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Parkinson-White Syndrome, or other significant downward
displacement of the ST-segment) (2).
Baseline clinical information. We collected the following
data from patients during a pre-ExECG interview: age,
symptoms, medication usage at the time of the ExECG,
and other coronary risk factors. Patients had height and
weight recorded. We classified chest pain using the three
categories of Diamond (6): typical angina, atypical angina,
and non-anginal chest pain. Risk factors included the
following: current or prior cigarette smoking, history of
hypertension (on antihypertensive therapy), history of
insulin- or noninsulin-requiring diabetes, history of high
cholesterol or on cholesterol-lowering therapy, a family
history of premature (60 years of age) coronary disease
(infarction, coronary bypass or angioplasty, sudden death) in
first-degree relatives, and obesity defined as a body-mass
index (kg/m2) 27. We determined estrogen status using
previously published criteria (7,8). Women were estrogen
status negative if they were postmenopausal and not receiv-
ing estrogen replacement therapy. If they were premeno-
pausal or receiving estrogen replacement therapy, they were
considered as estrogen status positive. Women who under-
went hysterectomy without oopherectomy were considered
estrogen status positive if they were under the age of 50 and
without symptoms of estrogen deficiency. Otherwise, they
were considered estrogen status negative.
Exercise tests. All patients exercised using the Cornell
treadmill protocol. We did not use predetermined peak
heart rates to determine when to stop exercise. We read all
studies in a blinded fashion.
Using the 12 standard leads, we measured peak exercise
or 3-min recovery ST-segment changes (60 ms following
the J-point compared to the baseline between 2 PR seg-
ments). We qualitatively categorized peak exercise ST
slope as upsloping, horizontal, or downsloping. Positive
ST-segment criteria consisted of 1 mm horizontal/
downsloping ST depression. For purposes of the Duke
treadmill score calculation, we considered any mm (1 mm)
of exercise-induced ST-segment depression (over baseline
measurements) that was associated with horizontal or
downsloping ST segments. Exercise-induced ST-segment
elevation was not considered in this analysis.
We also recorded resting and peak exercise heart rate and
blood pressure, exercise capacity estimated in metabolic
equivalents (METs), and exercise-induced angina. Because
the Duke treadmill score employs exercise duration using
the Bruce protocol, METs were converted to minutes of
exercise duration using the Bruce protocol by use of the
speed and elevation of the treadmill.
Angina during testing was classified according to the
Duke Treadmill Angina Index (2 if angina required stop-
ping the test, 1 if angina occurred during or after treadmill
test, and 0 for no angina) (9).
Score and end point determination. Utilizing the scores
presented in Figures 1A to 1C, each patient had the
following scores determined with respective assignment to
low-, intermediate-, and high-risk subgroups for each score:
Pretest score: low 0 to 8 points, intermediate 9 to 15
points, high 15 points (3).
Exercise test scores for men and women: low 0 to 39
points, intermediate 40 to 60 points, high 60 points (4,5).
For the purposes of this study, these two scores will be
considered as one score and referred to as the new exercise
score.
Duke treadmill score: low5 points, intermediate10
to 4 points, high 11 points (9).
The Duke treadmill score was calculated using the
following equation:
Bruce exercise minutes 5  mm ST depression)
4  Treadmill Angina Index)
Patients had vital status and date of death determined by a
search of the Social Security Death Index. Approval for
collection of follow-up data was obtained from our institu-
tional Human Subjects Committee.
Statistical analysis. The NCSS 2001 software (Number
Cruncher Statistical System) was used for all statistical
analyses. Comparison of frequencies was accomplished us-
ing chi-square testing. Comparison of means was accom-
plished using nonpaired t testing. Normality of data distri-
bution was determined using the Wilk-Shapiro test as well
as observation of box and normal probability plots. When
data were not distributed normally, the Mann-Whitney U
test was utilized. Survival analysis was accomplished using
Kaplan-Meier curves and Cox proportional hazards analy-
sis. A p value 0.05 was considered statistically significant.
Incremental stratifying value of the exercise scores over
the pretest score was assessed as follows. To demonstrate
incremental value, two things should occur: 1) the number
of correct classifications (low-probability patients who are
alive plus high-probability patients who are dead) should
significantly increase, and 2) the number of unclassified
patients (those with an intermediate pretest probability)
should significantly decrease.
RESULTS
Patient populations. During the period of interest, 4,640
symptomatic patients with suspected coronary disease and
interpretable ECGs underwent exercise testing with or
without simultaneous imaging (echocardiographic 992, or
21%; and nuclear 2,206, or 48%). See Table 1 for summary
Abbreviations and Acronyms
ACC/AHA  American College of Cardiology/
American Heart Association
ECG  electrocardiogram
ExECG  exercise electrocardiogram
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Figure 1. The details of how to calculate the pretest (A) and exercise scores are presented. There are exercise scores for men (B) and women (C). Both
exercise scores have the same exercise test variables with differing point assignments depending on gender. BMI body mass index; CAD coronary artery
disease. Continued on next page.
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of clinical and exercise test characteristics of the entire popu-
lation as well as selected subgroups defined by their clinical
relevance, such as inpatient/outpatient status at the time of the
exercise test, diabetic status (as defined earlier), and beta-
blocker status at the time of the exercise test. Prior reports have
presented the characteristics of the men and women (4,5).
Table 1. Clinical and Exercise Test Characteristics
All Inpatients Outpatients Diabetics Nondiabetics
Beta-
Blockers
No Beta-
Blockers
Number 4,640 665 3975 587 4,053 715 3,925
Age 50  12 47  13 50  13* 51  12 49  13* 53  12 49  13*
Women 2,176 (47) 276 (42) 1,900 (48)† 277 (47) 1,899 (47) 308 (43) 1,868 (48)‡
Symptoms
Typical 479 (10) 58 (9) 421 (11) 75 (13) 404 (10) 128 (18) 351 (9)
Atypical 1,985 (43) 287 (43) 1,698 (43) 242 (41) 1,743 (43) 271 (38) 1,714 (44)*
Nonanginal 2,176 (47) 320 (48) 1,856 (46) 270 (46) 1,906 (47) 316 (44) 1,860 (47)
Diabetes 587 (13) 81 (12) 506 (13) 587 (100) 0 (0) 113 (16) 474 (12)†
Smoking 2,272 (49) 383 (57) 1,889 (48)* 278 (47) 1,994 (49) 390 (55) 1,882 (48)†
Hyperlipidemia 1,606 (35) 208 (31) 1,398 (35) 282 (48) 1,324 (33)* 352 (49) 1,254 (32)*
Hypertension 1,769 (38) 241 (36) 1,528 (38) 352 (60) 1,417 (35)* 495 (69) 1,274 (32)*
Obesity 2,830 (61) 387 (58) 2,443 (61) 447 (76) 2,383 (59)* 453 (63) 2,377 (61)
Family history 2,404 (52) 362 (54) 2,042 (51) 319 (54) 2,085 (51) 396 (55) 2,008 (51)‡
Positive ST 707 (15) 80 (12) 627 (16)*‡ 95 (16) 612 (15) 151 (21) 556 (14)*
Peak
Heart rate 157  21 154  21 158  21* 148  21 159  21* 142  21 160  20*
Systolic BP 162  22 162  22 169  22* 171  24 168  22* 166  22 169  22*
METs 8.1  2.8 8.0  2.8 8.1  2.8 6.7  2.5 8.3  2.8* 7.7  2.6 8.2  2.9*
Exercise minutes 6.9  2.9 6.8  2.9 6.9  3.0 5.3  2.7 7.1  2.9* 6.5  2.7 7.0  3.0*
Duke angina
Limiting 364 (8) 51 (8) 313 (8) 61 (10) 303 (7)†† 83 (12) 281 (7)*
Nonlimiting 345 (7) 46 (7) 299 (8) 49 (8) 296 (7) 67 (9) 278 (7)
Values are n (%). *p  0.001, †p  0.01, ‡p  0.05 compared to column to the immediate left.
BP  blood pressure; METs  metabolic equivalents.
Figure 1 Continued.
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Scores. Table 2 summarizes the pretest, new exercise test,
and Duke treadmill score results. The outpatient, diabetic,
and beta-blockers subgroups had consistently higher pretest
and exercise test scores than their respective alternate
subgroups. The distribution of low-, intermediate-, and
high-risk patients differed for all subgroup comparisons and
scores, except the inpatient/outpatient comparison using the
Duke treadmill score.
Survival analysis. The mean follow-up for the group was
2.8  1.6 years (alive: 2.8  1.6 years, and dead: 2.5  1.7
years). Table 3 summarizes the all-cause mortality data for
all subgroups and for risk groups for each of the three scores.
Not shown are the results for men and women, which
mirrored nearly exactly the results seen by the entire group.
The men had slightly but significantly higher overall mor-
tality than the women (3.7% vs. 2.3%; p  0.01). For the
pretest and both exercise scores, there was significant
stratification within all subgroups. The mortality of the
low-risk Duke treadmill score groups varied from 1.8% to
3.7%, whereas the mortality of the low risk exercise score
groups was consistently below 2.0%.
Figure 2 displays the Kaplan-Meier curves for each of the
three scores comparing the low-risk group to a combined
intermediate- and high-risk group. These latter groups were
combined because of the relatively small number of high-
risk patients. For each score there was significant stratifica-
tion (p  0.000001); however, the clearest separation of the
low risk group from the other groups occurred with the new
exercise score. Figures 3 and 4 are similar to Figure 2 and
display Kaplan-Meier curves for selected subgroups using
only the new exercise score. In each case, a low-risk group
is clearly identified.
Cox proportional hazards analysis was performed with
scores as the independent variables. Univariate analysis
demonstrated that the pretest score (p  0.00001) and
exercise score (p  0.01) were significant predictors of the
time to death. However, the Duke score was not (p 0.10).
When both the pretest and exercise scores were included in
the model, both scores remained significant (pretest score
p  0.0003, exercise score p  0.043). When METs was
included in the model, these results did not change (pretest
score p 0.0003, exercise score p 0.02, METs p 0.18).
Table 2. Pretest and Exercise Scores
All Inpatients Outpatients Diabetics Nondiabetics
Beta-
Blockers
No Beta-
Blockers
Pretest score 10  4.5 9.7  4.3 10.1  4.5† 13.4  4.3 9.5  4.3* 11.7  4.3 9.7  4.4*
Pretest group
Low 1,803 (39) 288 (44) 151 (38) 101 (17) 1,702 (42) 168 (24) 1,635 (42)
Intermediate 2,262 (49) 301 (45) 1,961 (49)† 277 (47) 1,985 (49)* 410 (57) 1,852 (47)*
High 575 (12) 76 (11) 499 (13) 209 (36) 366 (9) 137 (19) 438 (11)
Exercise score 33  16 32  15 33  16† 45  15 31  16* 40  16 32  16*
Exercise group
Low 3,067 (66) 471 (71) 2,597 (65) 216 (37) 2,851 (70) 362 (51) 2,705 (69)
Intermediate 1,318 (28) 165 (25) 1,153 (29)† 278 (47) 1,040 (26)* 264 (37) 1,054 (27)*
High 255 (6) 30 (4) 225 (6) 93 (16) 162 (4) 89 (12) 166 (4)
Duke score 4.5  5.5 4.8  5.3 4.1  5.1 2.6  5.2 4.8  5.5* 3.1  6.3 4.7  5.3*
Duke group
Low 2,734 (59) 402 (60) 2,332 (59) 243 (41) 2,491 (61) 365 (51) 2,369 (60)
Intermediate 1,822 (35) 256 (39) 1,566 (39) 326 (56) 1,496 (37)* 323 (45) 1,499 (38)*
High 84 (2) 7 (1) 77 (2) 18 (3) 66 (2) 27 (4) 57 (2)
Values are n (%). *p  0.001, †p  0.05 compared to column to the immediate left.
Table 3. All-Cause Mortality Deaths (%)
All Inpatients Outpatients Diabetics Nondiabetics Beta-Blockers
No Beta-
Blockers
All 141 (3.0) 26 (3.9) 115 (2.9) 33 (5.6) 108 (2.7)* 25 (3.5) 116 (3.0)
1.1%/yr 1.4%/yr 1.0%/yr 2.0%/yr 0.9%/yr 1.3%/yr 1.1%/yr
Pretest group
Low 15 (0.8) 2 (0.7) 13 (0.9) 1 (1.0) 14 (0.8) 1 (0.6) 14 (0.9)
Intermediate 84 (3.7)* 17 (5.6)* 67 (3.4)* 16 (5.8)† 68 (3.4)* 12 (2.9)* 72 (3.9)*
High 42 (7.3) 7 (9.2) 35 (7.0) 16 (7.7) 26 (7.1) 12 (8.8) 30 (6.8)
Exercise group
Low 40 (1.3) 6 (1.3) 34 (1.3) 4 (1.9) 36 (1.3) 3 (0.8) 37 (1.4)
Intermediate 78 (5.9)* 17 (10.3)* 61 (5.3)* 19 (6.8)† 59 (5.7)* 16 (6.1)* 62 (5.9)*
High 23 (9.0) 3 (10) 20 (8.9) 10 (10.8) 13 (8.0) 6 (6.7) 17 (10.2)
Duke group
Low 53 (1.9) 10 (2.6) 43 (1.8) 9 (3.7) 44 (1.8) 10 (2.7) 43 (1.8)
Intermediate 80 (4.4)* 14 (5.2)* 66 (4.2)* 22 (6.7) 58 (3.9)* 11 (3.9)† 69 (4.6)*
High 8 (9.5) 2 (33) 6 (7.8) 2 (11) 6 (9.1) 4 (15) 4 (7.0)
Values are n (%). *p  0.0001, †p  0.05 compared to column to the immediate left.
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The ACC/AHA guidelines suggest that the value of
exercise testing differs according to pretest probability. They
also assigned a Class I indication to the intermediate pretest
probability group and only a Class IIb indication to the low
and high pretest probability groups. When an analysis like
that performed in Table 3 was limited to the intermediate
pretest probability subgroup, the patterns of stratification
were similar to what was seen on Table 3.
Table 4 presents mortality as a function of both the
pretest and the new and Duke exercise scores. Whereas
there was significant stratification using this approach espe-
cially for the intermediate pretest probability group, this
display does not completely reflect the incremental value of
the respective exercise scores over the pretest score.
Table 5 presents the results of our incremental value
analysis. The new exercise score demonstrated significant
incremental stratifying value over the pretest score given the
substantial increase in correctly classified patients and de-
crease in unclassified patients, as well as a decrease in
incorrectly classified patients. The Duke treadmill score
demonstrated a significantly smaller percent increase in
correctly classified patients and smaller percent decrease in
unclassified or intermediate-risk patients. The remaining
columns all assessed the incremental value of the new
exercise score over the pretest score. Except for two, all
subgroups demonstrated significant and substantial incre-
mental value, that is, an increase in correctly classified
patients and a decrease in unclassified patients. Compared
to the results in men, the use of the new exercise score in
women was associated with more modest increase in incre-
mental stratifying. In addition, the use of the new exercise
score in diabetics was associated with less incremental value
than in nondiabetics. Diabetics had a substantial increase in
correctly classified patients, but no change in the unclassi-
fied patients.
DISCUSSION
It is our observation that, in many institutions, ExECG has
been replaced by noninvasive imaging because of the per-
ception that it is of less value in clinical decision-making.
This is despite the presence of consensus guidelines that
clearly advocate its use as the initial evaluation in many
clinical situations, including suspected coronary disease. Its
jaded reputation in women, patients on beta-blockers, and
those with either poor exercise capacity or chronotropic
incompetence are familiar to all who utilize exercise testing
in any form. The guidelines for ExECG place no such
restrictions on its use in these populations. In fact, there are
recent studies suggesting that it is valuable in those popu-
lations (5,10–13).
The present study suggests that the utility of ExECG can
be enhanced by the use of multivariable scores. In addition,
its use and value in risk assessment can be extended to
Figure 2. Three Kaplan-Meier survival plots for low- and intermediate-high risk groups using pretest, exercise, and Duke treadmill scores.
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diabetics, women, inpatients, and those on beta-blockers
and the designation of low risk extends out to at least three
years across all subgroups. The ACC/AHA guidelines for
exercise testing (2) assigned a Class I indication to patients
with an intermediate pretest probability and a Class IIb
indication to those with a low or high pretest probability
concerning the diagnosis of coronary disease. From a
prognostic perspective, our results as reflected in Table 4
would suggest that these assignments are appropriate.
For low pretest probability patients, exercise testing will
most often confirm what is already appreciated from the
clinical assessment and will sometimes raise a question for
further testing (imaging). In other words, if a stress test is
considered for low probability patients, ExECG is the
appropriate first choice given its strong negative predictive
value (11).
For high pretest probability patients, only a minority will
be reclassified as low risk, so in the majority, the exercise test
will confirm what is already appreciated from the clinical
evaluation. A more appropriate initial strategy might be to
have these patients undergo either angiography or imaging
(14,15).
For intermediate pretest probability patients, our results
suggest that a low-risk ExECG result is associated with a
low risk of death. Even though these patients are at low risk
of death, they are not necessarily at low risk of having
significant coronary disease as a cause of their symptoms
(11). Therefore, in selected intermediate pretest probability
patients, an initial imaging strategy or follow-up imaging
will be needed to clarify what might be causing their
symptoms. Clearly more study is needed to determine the
incremental value of such strategies and how they might be
best applied.
Study limitations. The Duke treadmill score was derived
using cardiovascular death as its end point. On the other
hand, both the pretest score and the new exercise scores
were derived using the presence or absence of angiographic
coronary disease as their end point. The present study
utilized all-cause mortality rather than cardiovascular death
or angiography. This would seem to put all of these scores
at some degree of disadvantage. This may explain some of
the differences seen between the two exercise scores. This
study also did not consider other relevant end points such as
cardiovascular death, nonfatal myocardial infarction, stroke,
and coronary revascularization. We chose all-cause mortal-
ity because of its ease of determination and lack of bias (16).
We did not consider the results of noninvasive imaging that
were available in many of our patients. Our mortality data
were not censored for revascularization because these data
were not collected in this study.
Figure 3. Kaplan-Meier survival plots for low- and intermediate-high risk groups using the new exercise score in subgroups according to gender and diabetic
status.
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Exercise capacity as expressed by METs was not included
in the new exercise score because, at its derivation, it was not
selected as a predictor of angiographic coronary disease.
Despite this, the new exercise score stratified our population
well and was at least as good and perhaps slightly better than
the Duke treadmill score, which does include exercise
capacity. Given that the new exercise score does not include
exercise capacity, how did it perform as well as a score that
did include METs? Two explanations are possible. First, it
is possible that other pretest clinical data not included in the
Duke treadmill score made up the difference. However, a
more likely possibility is that exercise heart rate, a known
predictor of death, has sufficient predictive power to negate
the absence of exercise capacity (17).
We divided our population according to peak METs
achieved: 10 and 10 METs. As expected, the group
with lower peak METs was larger (3,018 vs. 1,622) and had
a higher mortality (3.8% vs. 1.5%; p  0.01). However, the
pretest and new exercise scores stratified both of these
groups well and in a manner mimicking what was seen in
Table 3. In addition, the incremental value of the new
exercise test was substantial in each (% increase in corrects:
low 57 vs. high 80, and % decrease in unclassifieds: low 25
vs. high 71), with the advantage going to the higher exercise
capacity group. Cox analysis also indicated that the predic-
tive power of the exercise score was not negated when
METs were included in the analysis. Therefore, although
the new exercise score does not contain exercise capacity as
Figure 4. Kaplan-Meier survival plots for low- and intermediate-high risk groups using the new exercise score in subgroups according to inpatient and
beta-blocker status.
Table 4. All-Cause Mortality Using Both Pretest Score and Either the New Exercise Score or the Duke Treadmill Score
Exercise Groups New Exercise Score Duke Treadmill Score
High 0/0 6/100 17/155 1/9 3/49 4/26
6% 11% 11% 6.1% 15%
2.1%/yr 3.9%/yr 4%/yr 2.2%/yr 5.5%/yr
Intermediate 1/48 53/884 24/386 9/566 44/876 27/380
2.1% 6% 6.2% 1.6% 5% 7.1%
0.8%/yr 2.1%/yr 2.2%/yr 0.5%/yr 1.8%/yr 2.6%/yr
Low 14/1,755 25/1,278 1/34 5/1,226 37/1,337 11/169
0.8% 2% 2.9% 0.4% 2.8% 6.5%
0.3%/yr 0.8%/yr 1%/yr 0.2%/yr 1%/yr 2.3%/yr
Low Intermediate* High Low* Intermediate* High
Pretest score subgroups
*p  0.05 for stratification by exercise score within respective pretest subgroup.
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a predictor variable, it stratifies at least as well as a score that
does contain exercise capacity, and performed well in groups
with differing exercise capacity.
The new exercise score, although simple by design, does
not consider many variables. For that reason, it might be less
precise in defining risk than a score that considered many
more variables. A preliminary report (18) of a more com-
plicated exercise score suggests that such a score is accurate,
but comparison to the present new exercise score has not
been undertaken to date.
Summary. In conclusion, simple pretest and exercise scores
risk stratify symptomatic patients with suspected coronary
disease well in accordance with published ACC/AHA
guidelines. A new exercise score risk stratifies patients at
least as well if not better than the Duke treadmill score.
These results extend to diabetics, inpatients, women, and
patients on beta-blockers.
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Table 5. Incremental Value of Exercise and Duke Scores Over Pretest Score
New
Score
Duke
Score Men Women Inpatients Outpatients Diabetics Nondiabetics BB
No
BB
Classification
Pretest score
Correct 1,830 1,830 572 1,258 293 1,537 116 1,714 179 1,651
Incorrect 548 548 236 312 71 477 194 354 126 422
Unclassified 2,262 2,262 1,656 606 301 1,961 277 1,985 410 1,852
Exercise score
Correct 3,050 2,719 1,547 1,503 467 2,583 222 2,828 365 2,685
Incorrect 272 129 162 110 33 239 87 185 86 186
Unclassified 1,318 1,822 755 563 165 1,153 278 1,040 264 1,054
% change correct 67 49* 170 19* 59 68 91 65* 104 63*
% change unclassified 42 19* 54 7* 45 41 1 48* 36 43
*p  0.001 compared to column to the immediate left
BB  beta-blockers; Correct  low risk alive  high risk dead; Incorrect  low risk dead  high risk alive; Unclassified  intermediate risk.
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